Copyright © 2004 by The Endocrine Society Further Lowering of Muscle Lipid Oxidative Capacity in Obese Subjects after Biliopancreatic DiversionR. Fabris, G. Mingrone, G. Milan, M. Manco, M. Granzotto, A. Dalla Pozza, A. Scarda, R. Serra, A. V. Greco, G. Federspil and R. VettorEndocrine-Metabolic Laboratory, (R.F., G.Mil., M.G., A.D.P., A.S., R.S., G.F., R.V.) Internal Medicine, Department of Medical and Surgical Sciences, University of Padova, 35128 Padova, Italy; and Department of Medicine, Catholic University (G.Min., M.M., A.V.G.), 8-00168 Rome, Italy Address all correspondence and requests for reprints to: Dr. Roberto Vettor, Department of Medical and Surgical Sciences, University of Padova, via Ospedale 105, 35128 Padova, Italy. E-mail: roberto.vettor{at}unipd.it.
A reduced lipid oxidative capacity is considered a risk factor for the development of obesity, but a further impairment of lipid oxidative capacity is observed after weight loss. We aimed to define the mechanisms underlying this phenomenon in skeletal muscle and in particular to study the mitochondrial and peroxisomal lipid oxidative pathways. Thus we measured intramyocellular triglyceride content (IMTG) and the expression of genes of lipid oxidation [peroxisome proliferator-activated receptor- This work was supported by grants from Ministero della Ricerca Scientifica e Tecnologica (no. 2001065883_003) and Ministero della Salute, Ricerca Finalizzata: OBEIR.
Abbreviations: ACAC, Acetyl-coenzyme A carboxylase; ACOX1, acyl-coenzyme A oxidase 1, palmitoyl; BPD, biliopancreatic diversion; BW, body weight; CoA, coenzyme A; CPT1, carnitine palmitoyltransferase 1; EE, energy expenditure; FFM, fat-free mass; FM, fat mass; IMTG, intramyocellular triglyceride content; NEFA, nonesterified fatty acid; PPAR
|